Results 261 to 270 of about 21,803,006 (294)
Some of the next articles are maybe not open access.
Current Opinion in Immunology, 2003
B cells act as immune effectors, primarily through antigen-specific clonal expansion and plasma-cell differentiation. B1 (CD5(+)) B cells and marginal zone B cells dominate T-cell independent humoral responses under the molecular control of activated dendritic cells.
openaire +2 more sources
B cells act as immune effectors, primarily through antigen-specific clonal expansion and plasma-cell differentiation. B1 (CD5(+)) B cells and marginal zone B cells dominate T-cell independent humoral responses under the molecular control of activated dendritic cells.
openaire +2 more sources
Current Opinion in Immunology, 1992
Discrimination between self and non-self in humoral immunity is mediated in part by elimination or inactivation of self-reactive B-cell clones. This type of repertoire censoring requires that self-reactive B cells make a choice between these and alternative cellular fates.
openaire +2 more sources
Discrimination between self and non-self in humoral immunity is mediated in part by elimination or inactivation of self-reactive B-cell clones. This type of repertoire censoring requires that self-reactive B cells make a choice between these and alternative cellular fates.
openaire +2 more sources
2010
Cellular reprogramming is an interplay between the original starting cell's plasticity and the (epi)genetic mechanisms used to drive this cell towards a new fate. Our capacity to reprogram mature cells into progenitors thus greatly depends on the inherent physiological plasticity of the initial cell.
openaire +2 more sources
Cellular reprogramming is an interplay between the original starting cell's plasticity and the (epi)genetic mechanisms used to drive this cell towards a new fate. Our capacity to reprogram mature cells into progenitors thus greatly depends on the inherent physiological plasticity of the initial cell.
openaire +2 more sources
Current Opinion in Immunology, 1992
Extraordinary progress has been made in refining our understanding of the B-cell antigen receptor complex, the role of protein-tyrosine phosphorylation as the key intermediary in immunoglobulin signal transduction, and in identifying candidate effectors of immunoglobulin-mediated signaling.
openaire +2 more sources
Extraordinary progress has been made in refining our understanding of the B-cell antigen receptor complex, the role of protein-tyrosine phosphorylation as the key intermediary in immunoglobulin signal transduction, and in identifying candidate effectors of immunoglobulin-mediated signaling.
openaire +2 more sources
2018
Mucosal B cells are crucial for host defense. The mucosal surfaces exceed 300 m2 in humans and represent indeed the largest part of the body in which immune responses take place daily. Mucosal B cells, located in the gut, respiratory, and urogenital mucosae as well as in skin, salivary, mammary, and lacrimal glands, are very important to protect ...
TROILO, A. +4 more
openaire +2 more sources
Mucosal B cells are crucial for host defense. The mucosal surfaces exceed 300 m2 in humans and represent indeed the largest part of the body in which immune responses take place daily. Mucosal B cells, located in the gut, respiratory, and urogenital mucosae as well as in skin, salivary, mammary, and lacrimal glands, are very important to protect ...
TROILO, A. +4 more
openaire +2 more sources
2004
Publisher Summary B-lymphocytes provide the humoral (antibody-mediated) arm of the adaptive immune system. Like all leukocytes, B cells develop from hematopoietic stem cells in the bone marrow. The bone marrow is a tissue where B cells of all developmental stages can be isolated.
openaire +2 more sources
Publisher Summary B-lymphocytes provide the humoral (antibody-mediated) arm of the adaptive immune system. Like all leukocytes, B cells develop from hematopoietic stem cells in the bone marrow. The bone marrow is a tissue where B cells of all developmental stages can be isolated.
openaire +2 more sources
Critical Care Management of Chimeric Antigen Receptor T-Cell Therapy Recipients
Ca-A Cancer Journal for Clinicians, 2022Sandrine Valadè +2 more
exaly